Profiel
Dr. Ruurd Stolp is President at Intervet, Inc. He is on the Board of Directors at Malcisbo AG.
Dr. Stolp was previously employed as President by Intervet International BV and President by Intervet.
He received his undergraduate degree from the University of Utrecht.
Actieve functies van Ruurd Stolp
| Bedrijven | Functie | Begin |
|---|---|---|
Intervet, Inc.
Intervet, Inc. Agricultural Commodities/MillingProcess Industries Develops, manufactures and sales animal health products | President | - |
Eerdere bekende functies van Ruurd Stolp
| Bedrijven | Functie | Einde |
|---|---|---|
Merck Animal Health
Merck Animal Health Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets veterinary medicines & vaccines | President | 01-01-2008 |
Intervet International BV
Intervet International BV Pharmaceuticals: MajorHealth Technology Develops and manufactures veterinary vaccines | President | 02-01-2007 |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Develops novel carbohydrate-based vaccines for human and animal health | Directeur/Bestuurslid | - |
Opleiding van Ruurd Stolp
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Intervet International BV
Intervet International BV Pharmaceuticals: MajorHealth Technology Develops and manufactures veterinary vaccines | Health Technology |
Intervet, Inc.
Intervet, Inc. Agricultural Commodities/MillingProcess Industries Develops, manufactures and sales animal health products | Process Industries |
University of Utrecht
University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Animal Health
Merck Animal Health Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets veterinary medicines & vaccines | Health Technology |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Develops novel carbohydrate-based vaccines for human and animal health | Health Technology |
















